Evidence map›Paper›PMID 33767213›Full record

ArticleScientific reports2021

Generalized chest CT and lab curves throughout the course of COVID-19.

Michael T Kassin, Nicole Varble, Maxime Blain, Sheng Xu, Evrim B Turkbey, Stephanie Harmon, Dong Yang, Ziyue Xu, Holger Roth, Daguang Xu and 13 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 3 countries.

Michael T Kassin *Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center and National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Nicole Varble *Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center and National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Maxime Blain *Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center and National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Sheng XuCenter for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center and National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Evrim B TurkbeyRadiology and Imaging Sciences, NIH Clinical Center, National Institutes of Health, Bethesda, MD, 20892-1182, USA.
Stephanie HarmonNational Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Dong YangNVIDIA Corporation, Bethesda, MD, 20892, USA.
Ziyue XuNVIDIA Corporation, Bethesda, MD, 20892, USA.
Holger RothNVIDIA Corporation, Bethesda, MD, 20892, USA.
Daguang XuNVIDIA Corporation, Bethesda, MD, 20892, USA.
Mona FloresNVIDIA Corporation, Santa Clara, CA, 95051, USA.
Amel AmalouCenter for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center and National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Kaiyun SunDivision of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, 20892, USA.
Sameer KadriCritical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, MD, 20892, USA.
Francesca PatellaDiagnostic and Interventional Radiology Service, ASST Santi Paolo e Carlo, Milan, Italy.
Maurizio CariatiDiagnostic and Interventional Radiology Service, ASST Santi Paolo e Carlo, Milan, Italy.
Alice ScarabelliPostgraduate School of Diagnostic and Interventional Radiology, University of Milan, Milan, Italy.
Elvira StellatoPostgraduate School of Diagnostic and Interventional Radiology, University of Milan, Milan, Italy.
Anna Maria IerardiDepartment of Radiology and Department of Health Sciences, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico and University of Milano, 20122, Milan, Italy.
Gianpaolo CarrafielloDepartment of Radiology and Department of Health Sciences, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico and University of Milano, 20122, Milan, Italy.
Peng AnDepartment of Radiology, Xiangyang NO. 1 People's Hospital Affiliated to Hubei University of Medicine, Xiangyang, Hubei, 441000, China.
Baris TurkbeyNational Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Bradford J WoodCenter for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center and National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. bwood@nih.gov.
National Institutes of Health Clinical Center · USNvidia (United States) · USNational Cancer Institute · USAzienda Socio Sanitaria Territoriale Santi Paolo e CarloFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITUniversity of Milan · ITHubei University of Medicine · CNNational Institute of Biomedical Imaging and Bioengineering · USNational Institutes of Health · USPhilips (United States) · US

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI PENDLETON, RICHARD · 2019 to 2025
$3932.6M
Center for Interventional OncologyZIDBC011242 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WOOD, BRADFORD J · 2009 to 2025
$18.7M
Imaging, image guided biopsy and treatment of prostate cancerZIABC012062 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TÜRKBEY, BARIS · 2021 to 2025
$1.3M
Development of COVID-19 Imaging Tools with Artificial IntelligenceZIABC011936 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WOOD, BRADFORD J · 2020 to 2025
$1.2M
Interventional OncologyZIACL040015 · CLC · CLINICAL CENTER · PI WOOD, BRADFORD · 2009 to 2025
$0k
Artificial Intelligence with Chest Imaging in COVID-19 and Isolation and Ventilator Devices for COVID-19ZIACL090072 · CLC · CLINICAL CENTER · PI WOOD, BRADFORD · 2020 to 2025
$0k
Intramural NIH HHS ZID BC011242National Institutes of Health, Center for Interventional Oncology Z01 1ZID BC011242NCI NIH HHS 75N91019D00024
6 · The paper itself

Abstract

A better understanding of temporal relationships between chest CT and labs may provide a reference for disease severity over the disease course. Generalized curves of lung opacity volume and density over time can be used as standardized references from well before symptoms develop to over a month after recovery, when residual lung opacities remain. 739 patients with COVID-19 underwent CT and RT-PCR in an outbreak setting between January 21st and April 12th, 2020. 29 of 739 patients had serial exams (121 CTs and 279 laboratory measurements) over 50 ± 16 days, with an average of 4.2 sequential CTs each. Sequential volumes of total lung, overall opacity and opacity subtypes (ground glass opacity [GGO] and consolidation) were extracted using deep learning and manual segmentation. Generalized temporal curves of CT and laboratory measurements were correlated. Lung opacities appeared 3.4 ± 2.2 days prior to symptom onset. Opacity peaked 1 day after symptom onset. GGO onset was earlier and resolved later than consolidation. Lactate dehydrogenase, and C-reactive protein peaked earlier than procalcitonin and leukopenia. The temporal relationships of quantitative CT features and clinical labs have distinctive patterns and peaks in relation to symptom onset, which may inform early clinical course in patients with mild COVID-19 pneumonia, or may shed light upon chronic lung effects or mechanisms of medical countermeasures in clinical trials.

Indexed as

Clinical Chemistry TestsHematologic TestsAdultCOVID-19FemaleHumansMaleMiddle AgedRetrospective StudiesSARS-CoV-2Severity of Illness IndexThoraxTomography, X-Ray Computed

Identifiers

PMID33767213
PMCPMC7994835
OpenAlexW3138664636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.